Picture of Medscope Holdings logo

MEDSC Medscope Holdings Cashflow Statement

0.000.00%
cy flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual cashflow statement for Medscope Holdings, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.452.713.345.635.76
Depreciation
Non-Cash Items-5.53-1.54-2.38-2.94-2.98
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.0110.158-2.0414.11.62
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-4.071.39-1.0116.84.46
Capital Expenditures-0.076-2.45
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2.37-18.2-8.27-22-4.29
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-2.45-20.6-8.27-22-4.29
Financing Cash Flow Items0.015
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities5.4831.3-3.354.780.015
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.0412-12.6-0.3940.184